3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Myelodysplastic Syndromes
12
Hematologic Neoplasms
7
Lymphoma
6
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia
5
Graft vs Host Disease
5
Primary Myelofibrosis
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Hodgkin Disease
4
Burkitt Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Anemia, Refractory, with Excess of Blasts
3
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Sezary Syndrome
2
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Polycythemia Vera
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Interventions
Bevacizumab
35
durvalumab
23
atezolizumab
22
Nivolumab
20
lenvatinib
19
tremelimumab
16
Specimen Handling
14
Magnetic Resonance Spectroscopy
12
sintilimab
11
pembrolizumab
9
Ipilimumab
9
tislelizumab
7
Sorafenib
7
cabozantinib
5
X-Rays
5
Immunoglobulin G
5
Disulfides
5
Cyclophosphamide
5
regorafenib
4
Radiotherapy
4
Radiosurgery
4
Radiation
4
Oxaliplatin
4
Immunotherapy
4
Ethiodized Oil
4
fludarabine
3
donafenib
3
Surgical Procedures, Operative
3
Folfox protocol
3
Fluorouracil
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Tacrolimus
×
90 days
×
Clear all
No trials found.